Brian T. Powl, Chief Commercial Officer at FATE THERAPEUTICS INC (FATE), sold 3,854 shares at $4.87 ($19K) on 2023-07-05, disclosed to the SEC on 2023-07-06.
Open-market sale of $19k FATE by Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| KURA | SELL | 2026-05-22 | $110K | — | Filing → |
| KURA | SELL | 2026-05-20 | $3K | — | Filing → |
| KURA | SELL | 2026-01-27 | $54K | — | Filing → |